Increased aromatase expression or activity has been observed in Sertoli and Leydig cell tumors, where aromatase gene mutations potentiate the local aromatization of excessive testosterone into estradiol within the tumor tissue itself [5,16]. This evidence concerns the gene CYP19A1 and neoplasm.